CLINICAL_TRIALS
trial_result
· 2016-10-05
Clinical Trial Update: Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis [Phase 2]
Summary
Pfizer's Phase 2 study of PF-04965842 for plaque psoriasis was terminated. The results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Plaque Psoriasis | Phase 2 | Status: TERMINATED | Results posted: 2016-10-05